225 related articles for article (PubMed ID: 33485325)
21. Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling.
Balabanian K; Levoye A; Klemm L; Lagane B; Hermine O; Harriague J; Baleux F; Arenzana-Seisdedos F; Bachelerie F
J Clin Invest; 2008 Mar; 118(3):1074-84. PubMed ID: 18274673
[TBL] [Abstract][Full Text] [Related]
22. Cerebellar involvement in warts Hypogammaglobulinemia immunodeficiency myelokathexis patients: neuroimaging and clinical findings.
Galli J; Pinelli L; Micheletti S; Palumbo G; Notarangelo LD; Lougaris V; Dotta L; Fazzi E; Badolato R
Orphanet J Rare Dis; 2019 Feb; 14(1):61. PubMed ID: 30819232
[TBL] [Abstract][Full Text] [Related]
23. The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse.
Kallikourdis M; Trovato AE; Anselmi F; Sarukhan A; Roselli G; Tassone L; Badolato R; Viola A
Blood; 2013 Aug; 122(5):666-73. PubMed ID: 23794067
[TBL] [Abstract][Full Text] [Related]
24. G protein-coupled receptor kinase-3-deficient mice exhibit WHIM syndrome features and attenuated inflammatory responses.
Tarrant TK; Billard MJ; Timoshchenko RG; McGinnis MW; Serafin DS; Foreman O; Esserman DA; Chao NJ; Lento WE; Lee DM; Patel D; Siderovski DP
J Leukoc Biol; 2013 Dec; 94(6):1243-51. PubMed ID: 23935208
[TBL] [Abstract][Full Text] [Related]
25. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12.
Balabanian K; Lagane B; Pablos JL; Laurent L; Planchenault T; Verola O; Lebbe C; Kerob D; Dupuy A; Hermine O; Nicolas JF; Latger-Cannard V; Bensoussan D; Bordigoni P; Baleux F; Le Deist F; Virelizier JL; Arenzana-Seisdedos F; Bachelerie F
Blood; 2005 Mar; 105(6):2449-57. PubMed ID: 15536153
[TBL] [Abstract][Full Text] [Related]
26. Separate elements are required for ligand-dependent and -independent internalization of metastatic potentiator CXCR4.
Futahashi Y; Komano J; Urano E; Aoki T; Hamatake M; Miyauchi K; Yoshida T; Koyanagi Y; Matsuda Z; Yamamoto N
Cancer Sci; 2007 Mar; 98(3):373-9. PubMed ID: 17270027
[TBL] [Abstract][Full Text] [Related]
27. AMD3100 is a potent antagonist at CXCR4(R334X) , a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome.
McDermott DH; Lopez J; Deng F; Liu Q; Ojode T; Chen H; Ulrick J; Kwatemaa N; Kelly C; Anaya-O'Brien S; Garofalo M; Marquesen M; Hilligoss D; DeCastro R; Malech HL; Murphy PM
J Cell Mol Med; 2011 Oct; 15(10):2071-81. PubMed ID: 21070597
[TBL] [Abstract][Full Text] [Related]
28. Recurrent CXCR4 sequence variation in a girl with WHIM syndrome.
Alapi K; Erdos M; Kovács G; Maródi L
Eur J Haematol; 2007 Jan; 78(1):86-8. PubMed ID: 17087743
[TBL] [Abstract][Full Text] [Related]
29. CXCR4 mutations in WHIM syndrome: a misguided immune system?
Diaz GA
Immunol Rev; 2005 Feb; 203():235-43. PubMed ID: 15661033
[TBL] [Abstract][Full Text] [Related]
30. Low-level Cxcr4-haploinsufficient HSC engraftment is sufficient to correct leukopenia in WHIM syndrome mice.
Gao JL; Owusu-Ansah A; Paun A; Beacht K; Yim E; Siwicki M; Yang A; Liu Q; McDermott DH; Murphy PM
JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31687976
[TBL] [Abstract][Full Text] [Related]
31. Clinical and Hematologic Effects of Endotoxin in Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome Model Mice.
Majumdar S; Gao JL; Pontejo SM; Balabanian K; Bachelerie F; Murphy PM
Immunohorizons; 2022 Jul; 6(7):543-558. PubMed ID: 35882421
[TBL] [Abstract][Full Text] [Related]
32. Long-Term Outcome of WHIM Syndrome in 18 Patients: High Risk of Lung Disease and HPV-Related Malignancies.
Dotta L; Notarangelo LD; Moratto D; Kumar R; Porta F; Soresina A; Lougaris V; Plebani A; Smith CIE; Norlin AC; Gòmez Raccio AC; Bubanska E; Bertolini P; Amendola G; Visentini M; Fiorilli M; Venuti A; Badolato R
J Allergy Clin Immunol Pract; 2019; 7(5):1568-1577. PubMed ID: 30716504
[TBL] [Abstract][Full Text] [Related]
33. WHIM syndrome: congenital immune deficiency disease.
Kawai T; Malech HL
Curr Opin Hematol; 2009 Jan; 16(1):20-6. PubMed ID: 19057201
[TBL] [Abstract][Full Text] [Related]
34. [CXCR4 as a rheostat of humoral response].
Khamyath M; Bonaud A; Balabanian K; Espéli M
Med Sci (Paris); 2023 Jan; 39(1):23-30. PubMed ID: 36692314
[TBL] [Abstract][Full Text] [Related]
35. CXCR4 signaling in health and disease.
Pozzobon T; Goldoni G; Viola A; Molon B
Immunol Lett; 2016 Sep; 177():6-15. PubMed ID: 27363619
[TBL] [Abstract][Full Text] [Related]
36. CXCR4 signaling controls dendritic cell location and activation at steady state and in inflammation.
Gallego C; Vétillard M; Calmette J; Roriz M; Marin-Esteban V; Evrard M; Aknin ML; Pionnier N; Lefrançois M; Mercier-Nomé F; Bertrand Y; Suarez F; Donadieu J; Ng LG; Balabanian K; Bachelerie F; Schlecht-Louf G
Blood; 2021 May; 137(20):2770-2784. PubMed ID: 33512478
[TBL] [Abstract][Full Text] [Related]
37. WHIM syndrome: a defect in CXCR4 signaling.
Diaz GA; Gulino AV
Curr Allergy Asthma Rep; 2005 Sep; 5(5):350-5. PubMed ID: 16091205
[TBL] [Abstract][Full Text] [Related]
38. Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients.
Tassone L; Moratto D; Vermi W; De Francesco M; Notarangelo LD; Porta F; Lougaris V; Facchetti F; Plebani A; Badolato R
Blood; 2010 Dec; 116(23):4870-3. PubMed ID: 20736454
[TBL] [Abstract][Full Text] [Related]
39. Adaptive Immunodeficiency in WHIM Syndrome.
Majumdar S; Murphy PM
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577453
[TBL] [Abstract][Full Text] [Related]
40. Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients.
Geier CB; Ellison M; Cruz R; Pawar S; Leiss-Piller A; Zmajkovicova K; McNulty SM; Yilmaz M; Evans MO; Gordon S; Ujhazi B; Wiest I; Abolhassani H; Aghamohammadi A; Barmettler S; Bhar S; Bondarenko A; Bolyard AA; Buchbinder D; Cada M; Cavieres M; Connelly JA; Dale DC; Deordieva E; Dorsey MJ; Drysdale SB; Ehl S; Elfeky R; Fioredda F; Firkin F; Förster-Waldl E; Geng B; Goda V; Gonzalez-Granado L; Grunebaum E; Grzesk E; Henrickson SE; Hilfanova A; Hiwatari M; Imai C; Ip W; Jyonouchi S; Kanegane H; Kawahara Y; Khojah AM; Kim VH; Kojić M; Kołtan S; Krivan G; Langguth D; Lau YL; Leung D; Miano M; Mersyanova I; Mousallem T; Muskat M; Naoum FA; Noronha SA; Ouederni M; Ozono S; Richmond GW; Sakovich I; Salzer U; Schuetz C; Seeborg FO; Sharapova SO; Sockel K; Volokha A; von Bonin M; Warnatz K; Wegehaupt O; Weinberg GA; Wong KJ; Worth A; Yu H; Zharankova Y; Zhao X; Devlin L; Badarau A; Csomos K; Keszei M; Pereira J; Taveras AG; Beaussant-Cohen SL; Ong MS; Shcherbina A; Walter JE
J Clin Immunol; 2022 Nov; 42(8):1748-1765. PubMed ID: 35947323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
